ClinicalTrials.Veeva

Menu

Outcomes of Endoscopic Operation in COVID-19 Infection: Cohort Study.

P

Peking University Cancer Hospital & Institute

Status

Not yet enrolling

Conditions

COVID-19
Surgery-Complications

Treatments

Procedure: endoscopic surgery

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The goal of this observational study is to determine 30-day mortality and post endoscopic surgery complications in patients with COVID-19 infection who undergo endoscopic surgery.This results will inform future risk stratification, decision making and improve patient's clinical care.This study is an investigator-led, non-commercial, non-interventional study is extremely low risk, or even zero risk.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients undergoing any type of endoscopic surgery in an operating theatre and these patients had COVID-19 infection either at the time of surgery or within 30 days of surgery.

Exclusion criteria

  • If COVID-19 infection is diagnosed >30 days after discharge, the patient should not be included.

Trial contacts and locations

1

Loading...

Central trial contact

Lin Chang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems